Commentary: BRAF inhibitors for metastatic melanoma
- PMID: 23445312
- DOI: 10.1111/bjd.12240
Commentary: BRAF inhibitors for metastatic melanoma
Comment on
-
A costly revolution for a subgroup of patients with metastatic melanoma.Br J Dermatol. 2013 Mar;168(3):467-70; discussion 470-1. doi: 10.1111/bjd.12238. Br J Dermatol. 2013. PMID: 23445310 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
